Clinuvel
- Thread starter johnnytech
- Start date
macgyver
Well-known member
Pharmaceutical: "We intend to add further complementary technologies by acquisition and in-licensing arrangements."
What would you need to in-license to complement a molecule that finds its way through the entire body freely except for the brain? It would be interesting to see if they could attach a molecule to afamelanotide that could help it penetrate the BBB negating the need for a direct injection into the brain itself (CNS).
Healthcare solutions: "Additionally, the intention is to add more proprietary molecules and excipients through acquisitions, expected to be completed the next 24 months."
Total speculation, but I wonder if they are looking for a technology that can better penetrate the dermal layers as they may not have found an ideal solution yet?
What would you need to in-license to complement a molecule that finds its way through the entire body freely except for the brain? It would be interesting to see if they could attach a molecule to afamelanotide that could help it penetrate the BBB negating the need for a direct injection into the brain itself (CNS).
Healthcare solutions: "Additionally, the intention is to add more proprietary molecules and excipients through acquisitions, expected to be completed the next 24 months."
Total speculation, but I wonder if they are looking for a technology that can better penetrate the dermal layers as they may not have found an ideal solution yet?
Johnny H
Well-known member
That, or "catch and kill" to maintain a competitive advantage.
Nearly 3 year on from when our chairman issued this address to the asx:
He said we were stupid to complain because CUV would be worth $7.5B in 4 years. And where are we at ….barely 750m or 10% of his target.
The ridiculous thing is, at a current sp of $15.50 we would be 20% better off, having just put our money in a bank account!
He said we were stupid to complain because CUV would be worth $7.5B in 4 years. And where are we at ….barely 750m or 10% of his target.
The ridiculous thing is, at a current sp of $15.50 we would be 20% better off, having just put our money in a bank account!
ironbark222
Well-known member
Over to you MOV, you have the floor.
Billy Boots
Well-known member
The trouble is that every communique we get it's sometime in the future and to be bloody realistic at my age how far down the f...track is MY FUTURE?
I think it's just an effort to address their historic slighting of the insects. That it's suggesting that we are shareholders and have rights including direction. I would need to see what questions are being put forward for a vote and what the question would be wored to sddress this particular right.
Newsletter: Non-event again.
CUV never fails to not deliver.
Great company, great management.
Huge respect for their approved proof-of-concept after 2 decades.
Clapping all the way.
As I said: Keep your expectations for rest of the year in the basement.
Just a matter of time until a lot of long term holders might select to exit and sell.
I guess not many will endure this much longer.
Will not end well with such a tightly held stock and low volumes.
At least PW and WB will loose heavily as well with their 3.5m and 1.5m shares held.
CUV never fails to not deliver.
Great company, great management.
Huge respect for their approved proof-of-concept after 2 decades.
Clapping all the way.
As I said: Keep your expectations for rest of the year in the basement.
Just a matter of time until a lot of long term holders might select to exit and sell.
I guess not many will endure this much longer.
Will not end well with such a tightly held stock and low volumes.
At least PW and WB will loose heavily as well with their 3.5m and 1.5m shares held.
Last edited:
investek
Well-known member
The battle continues!
US20200360484 - NDP-MSH FOR TREATMENT OF INFLAMMATORY AND/OR NEURODEGENERATIVE DISORDERS OF THE CNS
I appreciate that the Luger team may still be in charge of the admin/filing of this patent application (and may have lost some motivation due to the rights being signed over to CUV) but two months to remove some underlining seems excessive to me…
setting new yearly records , beating shorters , paving 9 paths to financial fur etc… how can one team have so much talent 